3391:TSETSURUHA Holdings, Inc. Analysis
Data as of 2026-06-13 - not real-time
¥2,079.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Tsuruha Holdings is trading at ¥2,079, which sits just above its 20‑day SMA (¥2,016.7) but remains under the 50‑day (¥2,111.9) and 200‑day (¥2,453.1) averages, signaling a short‑term pullback within a longer‑term bearish backdrop. The RSI of 53 suggests neutral momentum, while the MACD histogram is positive (≈23) and the MACD line sits above its signal, offering a bullish technical signal despite the overall bearish trend direction. Volume has been declining and 30‑day volatility is high at over 38%, indicating a choppy trading environment. The stock’s beta of –0.57 points to an inverse correlation with the broader market, which can provide a defensive edge when equities are under pressure. Valuation metrics are attractive: a trailing PE of 14.4 is well below the industry average of 24.8, and a forward PE of 3.3 implies substantial earnings upside.
The DCF‑derived fair value of ¥2,087 is essentially in line with the current price, yet analyst consensus targets around ¥2,600‑2,650 imply a potential upside of roughly 25%. The dividend yield of 2.31% with a payout ratio near 35% appears sustainable given the company’s strong cash position (¥202 bn) despite a high debt‑to‑equity ratio. The market sentiment index reads “Extreme Greed” (89.9), which may be inflating short‑term buying pressure. With no revenue growth this year but a projected forward EPS jump from ¥144 to ¥625, the earnings trajectory is driven more by margin expansion and ancillary services than top‑line expansion. Overall, the blend of defensive valuation, modest dividend, and analyst‑driven upside supports a cautiously optimistic stance for investors willing to navigate the near‑term volatility.
The DCF‑derived fair value of ¥2,087 is essentially in line with the current price, yet analyst consensus targets around ¥2,600‑2,650 imply a potential upside of roughly 25%. The dividend yield of 2.31% with a payout ratio near 35% appears sustainable given the company’s strong cash position (¥202 bn) despite a high debt‑to‑equity ratio. The market sentiment index reads “Extreme Greed” (89.9), which may be inflating short‑term buying pressure. With no revenue growth this year but a projected forward EPS jump from ¥144 to ¥625, the earnings trajectory is driven more by margin expansion and ancillary services than top‑line expansion. Overall, the blend of defensive valuation, modest dividend, and analyst‑driven upside supports a cautiously optimistic stance for investors willing to navigate the near‑term volatility.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price hovering below the 50‑day SMA
- decreasing volume and high volatility
- bearish trend despite bullish MACD histogram
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- valuation gap versus industry PE
- forward earnings expansion (PE 3.3)
- analyst target upside of ~25%
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- sustainable dividend supported by strong cash flow
- defensive negative beta profile
- growth potential from ancillary services and wellness care
Key Metrics & Analysis
Financial Health
Profit Margin2.94%
P/E Ratio14.4
ROE7.55%
ROA3.53%
Debt/Equity23.28
P/B Ratio1.1
Op. Cash Flow¥84.6B
Free Cash Flow¥71.9B
Industry P/E24.8
Technical Analysis
TrendBearish
RSI53.4
Support¥1,889.00
Resistance¥2,147.00
MA 20¥2,016.70
MA 50¥2,111.91
MA 200¥2,453.08
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Fair Value¥2,087.46
Target Price¥2,596.67
Upside/Downside24.90%
GradeUndervalued
TypeBlend
Dividend Yield2.31%
Risk Assessment
Beta-0.57
Volatility38.34%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.